|
|
|
Terumo Interventional Systems Launches
Pinnacle® R/O II HiFlo for Superficial Access SOMERSET, NJ, January 11, 2007 - Terumo Interventional Systems, a strategic business unit of medical device manufacturer Terumo Medical Corporation, has introduced an addition to its line of Pinnacle sheaths; the Pinnacle R/O II HiFlo Introducer Sheath. This product launch further advances Terumo’s leadership position in endovascular medicine. The new 4 cm, stiff introducer sheath features the Pinnacle’s recognized smooth transition which facilitates access to difficult superficial sites that may also be close to the location of a lesion. In addition, a larger diameter side flow tube allows a higher flow rate of fluids. “With the addition of the Pinnacle R/O II HiFlo, the Pinnacle line now includes a product specifically designed for the special needs of superficial access procedures,” said John Rooney, Vice President Marketing, Terumo Interventional Systems. “Our customers told us they needed a more efficient way to access and complete these procedures, and we believe the Pinnacle R/O II HiFlo fulfills that need.” The Pinnacle R/O II HiFlo also features a radiopaque marker band 5 mm from the tip for enhanced visibility, a laminar flow sheath housing with a 45? side tube take-off to improve flow dynamics, and a detachable 3-way stop cock. For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Customer Care Team at 800-862-4143 or by visiting http://www.terumomedical.com/interventional. Terumo Interventional Systems Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures. Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists and Vascular Surgeons are among the medical professionals that depend upon TIS products to access and cross difficult-to-reach lesions thereby allowing therapeutic intervention in previously unreachable vascular beds. Terumo Medical Corporation Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products, and a line of sterile connection devices used in hospitals and blood banks worldwide. Terumo Corporation Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $2.3 billion in sales and operations in more than 150 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543:JP) and is a component of the Nikkei 225, Japan’s leading stock index. Source: Terumo Medical Corporation |
Angioplasty.Org Home • PatientCenter
this press release is posted as a reader
service by Angioplasty.org,
an editorially independent informational health
site
which has received unrestricted educational grants from
Medtronic plc,
TCROSS NEWS, Toshiba
America
Medical Systems, Volcano
Corporation, Terumo
Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021
